Technical Analysis for HBIO - Harvard Bioscience, Inc.

Grade Last Price % Change Price Change
grade C 3.12 -4.00% -0.13
HBIO closed up 3.83 percent on Tuesday, November 19, 2019, on 66 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical HBIO trend table...

Date Alert Name Type % Chg
MACD Bullish Centerline Cross Bullish -4.00%
Upper Bollinger Band Walk Strength -4.00%
Above Upper BB Strength -4.00%
Overbought Stochastic Strength -4.00%
Up 3 Days in a Row Strength -4.00%
Up 4 Days in a Row Strength -4.00%
Upper Bollinger Band Touch Strength -4.00%
Stochastic Reached Overbought Strength -0.32%
Above Upper BB Strength -0.32%
Overbought Stochastic Strength -0.32%

Older signals for HBIO ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Harvard Bioscience, Inc., together with its subsidiaries, develops, manufactures, distributes, and markets specialized products, primarily apparatus and scientific instruments used to advance life science research and regenerative medicine. It operates through two segments, Life Science Research Tools and Regenerative Medicine Device. The company's products primarily target ADMET testing and molecular biology application areas. Its ADMET testing products include absorption diffusion chambers that measure the absorption of a drug into the bloodstream; well equilibrium dialysis plate for serum protein binding assays; organ testing systems; infusion pumps; behavioral products used in neuroscience, cardiology, psychological, and respiratory studies to evaluate the effects of situational stimuli, drugs, and nutritional infusions on motor and sensory, activity, and learning and test behavior; cell injection systems; ventilators; and electroporation products. The company's molecular biology products include molecular biology spectrophotometers, DNA/RNA/protein calculators, multi-well plate readers, liquid dispensers, and amino acid analysis and gel electrophoresis systems, as well as liquid handling consumables, such as pipettes, pipette tips, autoradiography films, gloves, thermal cycler accessories, and reagents. It also distributes devices, instruments, and consumables used in experiments involving cells, tissues, organs, and animals in the fields of proteomics, physiology, pharmacology, neuroscience, cell biology, molecular biology, and toxicology; and manufactures microdialysis products, synthetic scaffolds, bioreactors, and cell biology and electrophysiology products. The company sells its products to pharmaceutical and biotechnology companies, universities, and government laboratories through distributors, catalogs, and its field sales organization and Website worldwide. Harvard Bioscience, Inc. was founded in 1901 and is headquartered in Holliston, Massachusetts.
Chemistry Biotechnology Physical Sciences Natural Sciences Neuroscience Molecular Biology Dialysis Cell Biology Agilent Technologies Regenerative Medicine Proteomics Gel Electrophoresis
Is HBIO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 4.66
52 Week Low 1.51
Average Volume 130,773
200-Day Moving Average 2.9428
50-Day Moving Average 2.927
20-Day Moving Average 2.7595
10-Day Moving Average 2.739
Average True Range 0.1967
ADX 24.37
+DI 33.3079
-DI 17.2729
Chandelier Exit (Long, 3 ATRs ) 2.6599
Chandelier Exit (Short, 3 ATRs ) 2.9901
Upper Bollinger Band 3.1581
Lower Bollinger Band 2.3609
Percent B (%b) 1.12
BandWidth 28.889292
MACD Line 0.0293
MACD Signal Line -0.0367
MACD Histogram 0.066
Fundamentals Value
Market Cap 113.21 Million
Num Shares 34.8 Million
EPS -0.13
Price-to-Earnings (P/E) Ratio -25.00
Price-to-Sales 1.19
Price-to-Book 1.60
PEG Ratio 2.65
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.55
Resistance 3 (R3) 3.52 3.38 3.50
Resistance 2 (R2) 3.38 3.31 3.40 3.48
Resistance 1 (R1) 3.32 3.26 3.35 3.35 3.47
Pivot Point 3.18 3.18 3.20 3.20 3.18
Support 1 (S1) 3.12 3.11 3.15 3.15 3.03
Support 2 (S2) 2.98 3.06 3.00 3.02
Support 3 (S3) 2.92 2.98 3.00
Support 4 (S4) 2.95